| Hans-Günter Meyer-Thompson | Legal
U.S. cannabis laws projected to cost generic and brand pharmaceutical firms billions.
U.S. cannabis laws projected to cost generic and brand pharmaceutical firms billions.
Bednarek Z, Doremus JM, Stith SS (2022)
PLoS ONE 17(8): e0272492. doi.org/10.1371/journal.pone.0272492
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0272492